Humana Inc. (NYSE:HUM) Stake Raised by 180 Wealth Advisors LLC

180 Wealth Advisors LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 8.1% in the first quarter, HoldingsChannel reports. The fund owned 1,023 shares of the insurance provider’s stock after buying an additional 77 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Humana were worth $355,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Rakuten Securities Inc. acquired a new stake in shares of Humana during the fourth quarter worth approximately $25,000. Gradient Investments LLC boosted its stake in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the period. Cetera Trust Company N.A purchased a new position in shares of Humana during the 4th quarter valued at $28,000. Private Wealth Management Group LLC acquired a new position in shares of Humana in the fourth quarter worth $32,000. Finally, Carolinas Wealth Consulting LLC raised its holdings in shares of Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after acquiring an additional 74 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Robert W. Baird initiated coverage on Humana in a research note on Thursday, May 30th. They issued a “neutral” rating and a $374.00 target price on the stock. Wells Fargo & Company lowered their price target on Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reissued a “neutral” rating and issued a $360.00 target price on shares of Humana in a research report on Wednesday, June 12th. Finally, Oppenheimer dropped their price target on shares of Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research note on Thursday, April 25th. Fourteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $409.55.

Humana Stock Performance

Shares of Humana stock traded up $17.19 during midday trading on Friday, hitting $380.17. The company had a trading volume of 1,519,093 shares, compared to its average volume of 1,797,316. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The business’s 50 day simple moving average is $342.12 and its two-hundred day simple moving average is $353.32. The stock has a market cap of $45.81 billion, a PE ratio of 22.60, a P/E/G ratio of 2.09 and a beta of 0.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s quarterly revenue was up 10.7% on a year-over-year basis. During the same period last year, the business posted $9.38 EPS. As a group, equities analysts predict that Humana Inc. will post 16.27 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 0.93%. Humana’s dividend payout ratio (DPR) is 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.